HC Wainwright & Co. reiterated coverage on Forma Therapeutics Hldgs with a new price target
$FMTX
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of Forma Therapeutics Hldgs with a rating of Buy and set a new price target of $53.00 from $55.00 previously